STAGE IV PANCREATIC CANCER AJCC V6 AND V7
Clinical trials for STAGE IV PANCREATIC CANCER AJCC V6 AND V7 explained in plain language.
Never miss a new study
Get alerted when new STAGE IV PANCREATIC CANCER AJCC V6 AND V7 trials appear
Sign up with your email to follow new studies for STAGE IV PANCREATIC CANCER AJCC V6 AND V7, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug combo takes on tough cancers: early trial hopes for better control
Disease control OngoingThis early-phase trial is testing a combination of two drugs—guadecitabine and durvalumab—in people with advanced liver, pancreatic, bile duct, or gallbladder cancers that have spread. Guadecitabine aims to block cancer cell growth, while durvalumab helps the immune system attack…
Matched conditions: STAGE IV PANCREATIC CANCER AJCC V6 AND V7
Phase: PHASE1 • Sponsor: University of Southern California • Aim: Disease control
Last updated Jun 22, 2026 11:55 UTC
-
New drug combo shows promise in Hard-to-Treat cancers
Disease control OngoingThis study tests a combination of two drugs, cediranib and olaparib, in people with advanced solid tumors that have spread or cannot be removed by surgery. The cancers include certain types of breast, lung, and pancreatic cancer. The goal is to see if the combination can shrink t…
Matched conditions: STAGE IV PANCREATIC CANCER AJCC V6 AND V7
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 17, 2026 12:09 UTC
-
Could a diabetes drug and supplements boost chemo for pancreatic cancer?
Disease control OngoingThis early-phase trial tests the safety and feasibility of adding the diabetes drug metformin and a specific dietary supplement blend to standard chemotherapy (gemcitabine and Abraxane) for people with pancreatic cancer that cannot be removed by surgery. The study involves 21 par…
Matched conditions: STAGE IV PANCREATIC CANCER AJCC V6 AND V7
Phase: PHASE1 • Sponsor: City of Hope Medical Center • Aim: Disease control
Last updated Jun 15, 2026 19:08 UTC
-
Experimental drug cocktail targets Hard-to-Treat cancers
Disease control OngoingThis early-phase study tests a combination of two targeted drugs (vismodegib and erlotinib) with or without a standard chemotherapy drug (gemcitabine) in people with advanced pancreatic cancer or other solid tumors that cannot be removed by surgery. The main goal is to find the s…
Matched conditions: STAGE IV PANCREATIC CANCER AJCC V6 AND V7
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 15, 2026 19:07 UTC
-
Experimental vaccine targets Hard-to-Treat pancreatic cancer
Disease control OngoingThis early-phase study tested a vaccine therapy given directly into the tumor along with a growth factor to boost the immune system in 18 people with advanced pancreatic cancer that could not be removed by surgery. The main goal was to find the safest dose and check for side effe…
Matched conditions: STAGE IV PANCREATIC CANCER AJCC V6 AND V7
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 15, 2026 18:54 UTC
-
New drug cocktail targets tough pancreatic cancer
Disease control OngoingThis early-phase study tested a combination of three drugs (gemcitabine, dasatinib, and erlotinib) in 19 people with advanced pancreatic cancer that had spread or could not be removed by surgery. The main goal was to find the safest dose and look at side effects. Researchers also…
Matched conditions: STAGE IV PANCREATIC CANCER AJCC V6 AND V7
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 10, 2026 13:28 UTC
-
New drug hopes to boost Radiation's punch against tough gut cancers
Symptom relief OngoingThis early-phase study tests an oral drug called ropidoxuridine (IPdR) in people with advanced gastrointestinal cancers that cannot be cured. The goal is to find the safest dose and see if it can make radiation therapy more effective at shrinking tumors. Nineteen participants wit…
Matched conditions: STAGE IV PANCREATIC CANCER AJCC V6 AND V7
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Symptom relief
Last updated Jun 10, 2026 13:24 UTC